Topics

NHS England strikes deal with Orkambi manufacturer

11:47 EDT 24 Oct 2019 | The Pharmaceutical Journal

Patients in England with cystic fibrosis will now have access to three new cystic fibrosis drugs on the NHS, following an agreement between the manufacturer and the government.

Original Article: NHS England strikes deal with Orkambi manufacturer

NEXT ARTICLE

More From BioPortfolio on "NHS England strikes deal with Orkambi manufacturer"

Quick Search

Relevant Topics

Cystic Fibrosis
Affecting over 8,500 people in the UK, Cystic Fibrosis (CF) is one of the UK's most common life-threatening inherited diseases. Around half of the CF population can expect to live over 38 years, although improvements in treatments mean a baby born ...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...